超声微泡造影剂在疾病诊疗中的发展与应用
evelopments and applications of ultrasound contrast agents in the diagnose and treatment of diseases
超声微泡造影剂(Ultrasound contrast agents, UCAs)应用于超声成像已有将近五十年的历史。随着科技进步和医学影像学的发展，人们发现UCA除了能够增强显影，更可作为一种具有生物屏障穿透性的基因及药物递送载体，在疾病的诊断与治疗两个方面同时发挥优势。根据近年来国内外学者在超声医学领域的探索，本文阐述了UCA的研究进展，并就其在疾病诊疗、临床应用方面的发展前景及挑战进行了探讨。
he application of ultrasound contrast agents (UCAs) in ultrasound imaging started out about fifty years ago. With the development of technology and medical imaging, we realize that, besides enhancing imaging, UCA could be applied as ideal carriers in both gene and drug delivery. Based on the latest investigations throughout the world, this paper reviews the current developments and the clinical applications of UCA, as well as the prospects and challenges in the diagnose and treatment of diseases.
刘全宏、王筱冰、杨爽
医药卫生理论医学现状、医学发展基础医学
超声造影剂微泡载体靶向疾病诊断疾病治疗
ultrasound contrast agentmicrobububblescarriertargeteddiagnosetreatment
刘全宏,王筱冰,杨爽.超声微泡造影剂在疾病诊疗中的发展与应用[EB/OL].(2013-09-11)[2025-08-18].http://www.paper.edu.cn/releasepaper/content/201309-157.点此复制
评论